-
Mashup Score: 0TRANSFORM-HF Trial Found No Difference in Effectiveness Between 2 Common Loop Diuretics - 2 year(s) ago
November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication furosemide or torsemide had similar death and hospitalization rates, according to late-breaking science researchpresented today at the American Heart Association’s Scientific Sessions 2022. The meeting, held in person in Chicago and virtually, Nov. 5-7, 2022, is a premier global…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
November 7, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but did not improve clinical outcomes compared to people who received early conservative therapy, according to late-breaking clinical trial results presented today at the American Heart…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @AHAMeetings A randomized trial using #ECMO devices to treat #cardiogenicshock found that those who received immediate ECMO had comparable outcomes to those who initially received conservative therapy: https://t.co/PZSo4V9qIF #AHA2022
-
-
Mashup Score: 0Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing - 2 year(s) ago
November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results that show evaluating patients with suspected CAD by applying advanced artificial intelligence (AI) to CCTA allows for more accurate non-invasive diagnosis, reduces unnecessary testing, and offers higher confidence in identifying patients needing treatment. The results from…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @HeartFlow @AHAMeetings Using #CCTA)with HeartFlow’s #FFRCT_Analysis to evaluate suspected #CAD offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment: https://t.co/rqogozTTaj #AHA2022
-
-
Mashup Score: 97
Original Article from The New England Journal of Medicine — Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
RT @BEST_CLI: We are out in the world of evidence 🎉Enjoy the science, cardiovascular peeps!!!! #AHA2022 https://t.co/GZaH2zQdRb
-
-
Mashup Score: 1
Aim: This clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients. Method
Source: CirculationCategories: Cardiologists, Latest HeadlinesTweet-
What a great talk on Imaging Highlights of CP Guidelines https://t.co/0RTVHbhNBo by @RBP0612. Truly a Masterpiece. @iamritu @JGrapsa #AHA2022 @CircAHA @JACCJournals #ACCWIC #AHAWIC #WomeninCardiology @echofirst @Heart_SCCT https://t.co/H8Wf0jLUQo
-
-
Mashup Score: 4Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project) - 2 year(s) ago
Background: Coronary artery calcium (CAC) can be identified on non-gated chest CTs, but this finding is not consistently incorporated into care. A deep learning algorithm enables opportunistic CAC sc
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: Notifying clinicians and statin-naïve patients of incidental #CAC identified on prior, non-gated chest CT via #AI DL algorithm increased statin rates to 51% (vs 7% in usual care). @ATSandhu https://t.co/Vm2pIJ9gpV https://t.co/Q3GJc2qXOJ
-
-
Mashup Score: 11Empagliflozin in Black Versus White Patients with Heart Failure: Analysis of EMPEROR-Pooled - 2 year(s) ago
Nitish K. DhingraNitish K. Dhingra Division of Cardiac Surgery, St. Michael’s Hospital, University of Toronto, Toronto, Canada , Stefan D. AnkerStefan D. Anker https://orcid.org/0000-0002-0805-8683 Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin,…
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: The efficacy and safety of #empagliflozin was similar in Black and White patients with HF across the range of EF, with a suggestion of enhanced efficacy in Black patient... @JavedButler1 @FaiezZANNAD @lamcardio https://t.co/c7LMA1O9yL https://t.co/8wihsizMAK
-
-
Mashup Score: 43
Original Article from The New England Journal of Medicine — Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
RT @BEST_CLI: We are out in the world of evidence 🎉Enjoy the science, cardiovascular peeps!!!! #AHA2022 https://t.co/GZaH2zQdRb
-
-
Mashup Score: 9Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study - 2 year(s) ago
Background: Long term outcomes of antiplatelet monotherapy in patients who receive percutaneous coronary intervention (PCI) are unknown. The HOST-EXAM Extended study reports the post-trial follow-up
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: In the #HOST-EXAM Extended Study, clopidogrel monotherapy had lower risk of thrombotic and bleeding events compared w/ aspirin monotherapy among patients w/o clinical events for 12mo after DES https://t.co/aI4xjHdBaB https://t.co/2sPcy9279N
-
-
Mashup Score: 0Association of a Multi-Ancestry Genome-Wide Blood Pressure Polygenic Risk Score with Adverse Cardiovascular Events - 2 year(s) ago
Background – Traditional cardiovascular (CV) risk factors and the underlying genetic risk of elevated blood pressure (BP) determine an individual’s composite risk of developing adverse CV events. We
Categories: Hem/Oncs, Latest HeadlinesTweet-
.@NIH-funded: In a multi-ancestry cohort of >21,000 US adults, genome-wide SBP PRS was associated with BP traits & adverse CV events. Control of modifiable CV risk factors may reduce adverse CV risk among those with a high SBP PRS #NHLBI #TOPMed #AHA2022 https://t.co/HshIC7Fc5P https://t.co/RIHbyqiYEt
-
@DAICeditor @AHAMeetings #Researchers say health care professionals should now focus on appropriate dosing of #diuretics and implementation of medicines proven to improve quality-of-life and clinical outcomes for people living with #heartfailure: https://t.co/7NYkravPk9 #AHA2022